-
EP3447047
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3447047
| EP3447047 - CRYSTAL POLYMORPHISM OF KCNQ 2-5 CHANNEL ACTIVATOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.07.2020 Database last updated on 20.07.2024 | |
| Former | Grant of patent is intended Status updated on 10.09.2019 | ||
| Former | Request for examination was made Status updated on 25.01.2019 | ||
| Former | The international publication has been made Status updated on 28.10.2017 | Most recent event Tooltip | 10.07.2020 | Application deemed to be withdrawn | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states ONO Pharmaceutical Co., Ltd. 1-5, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-8526 / JP | [2019/09] | Inventor(s) | 01 /
YASHIRO, Kentaro c/o ONO PHARMACEUTICAL CO. LTD. 1-1 Sakurai 3-chome Shimamoto-cho Mishima-gun Osaka 618-8585 / JP | 02 /
KIJIMA, Hideomi c/o ONO PHARMACEUTICAL CO. LTD. 1-1 Sakurai 3-chome Shimamoto-cho Mishima-gun Osaka 618-8585 / JP | 03 /
WAKAMATSU, Daisuke c/o ONO PHARMACEUTICAL CO. LTD. 1-1 Sakurai 3-chome Shimamoto-cho Mishima-gun Osaka 618-8585 / JP | 04 /
SAITO, Tetsuji c/o ONO PHARMACEUTICAL CO. LTD. 1-1 Sakurai 3-chome Shimamoto-cho Mishima-gun Osaka 618-8585 / JP | [2019/09] | Representative(s) | Jones, Nicholas Andrew Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [N/P] |
| Former [2019/09] | Jones, Nicholas Andrew Withers & Rogers LLP 4 More London Riverside London, SE1 2AU / GB | Application number, filing date | 17786062.4 | 21.04.2017 | [2019/09] | WO2017JP16109 | Priority number, date | JP20160086239 | 22.04.2016 Original published format: JP 2016086239 | [2019/09] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017183725 | Date: | 26.10.2017 | Language: | JA | [2017/43] | Type: | A1 Application with search report | No.: | EP3447047 | Date: | 27.02.2019 | Language: | EN | [2019/09] | Search report(s) | International search report - published on: | JP | 26.10.2017 | (Supplementary) European search report - dispatched on: | EP | 04.01.2019 | Classification | IPC: | C07D213/61, A61K31/44, A61P13/10 | [2019/09] | CPC: |
C07D213/61 (EP,KR,US);
A61K31/44 (KR);
A61K9/2013 (US);
A61K9/2018 (US);
A61K9/2054 (US);
A61K9/2095 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/09] | Title | German: | KRISTALLPOLYMORPHISMUS DES KCNQ-2-5-KANAL-AKTIVATORS | [2019/09] | English: | CRYSTAL POLYMORPHISM OF KCNQ 2-5 CHANNEL ACTIVATOR | [2019/09] | French: | POLYMORPHISME CRISTALLIN DE L'ACTIVATEUR DES CANAUX KCNQ 2-5 | [2019/09] | Entry into regional phase | 18.10.2018 | Translation filed | 18.10.2018 | National basic fee paid | 18.10.2018 | Search fee paid | 18.10.2018 | Designation fee(s) paid | 18.10.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 18.10.2018 | Examination requested [2019/09] | 22.07.2019 | Amendment by applicant (claims and/or description) | 11.09.2019 | Communication of intention to grant the patent | 22.01.2020 | Application deemed to be withdrawn, date of legal effect [2020/33] | 27.02.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2020/33] | Fees paid | Renewal fee | 09.04.2019 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]WO2006029623 (LUNDBECK & CO AS H [DK], et al) [AD] 1-17 * page 32, line 28 - page 33, line 2; example -; claims 1, 13, 15 *; | [ED]EP3210969 (ONO PHARMACEUTICAL CO [JP]) [ED] 1-17* paragraphs [0098] , [ 150]; example 25(5); claims 1, 8, 13-19; tables 1-5 * | International search | [A]JP2010535244 (Valeant Pharmaceuticals International) [A] 1-21* , entire text & US 2009/0170885 A1 & WO 2009/018466 A1 & EP 2183250 A1 & EP 2311836 A1 & DE 602008004555 D & AU 2008282118 A & CA 2695196 A & KR 10-2010-0068373 A & CN 101778848 A & MX 2010001189 A & AT 495175 T & ES 2359601 T & RU 2010107284 A & TW 200922571 A *; | [A]JP2015514728 (Gruenenthal GmbH) [A] 1-21 * , entire text & WO 2013/156154 A1 & EP 2888233 A1 & CA 2870573 A & AU 2013248637 A & AR 90739 A & EA 201401142 A & MX 2014012494 A & CN 104428287 A & HK 1210173 A *; | [A]JP2016508960 (Gruenenthal GmbH) [A] 1-21 * , entire text & US 2014/0148468 A1 & WO 2014/082737 A1 & EP 2951156 A1 & CA 2892745 A & AU 2013351550 A *; | [PX]WO2016063990 (ONO PHARMACEUTICAL CO [JP]) [PX] 1-21 * , particularly, example 25(5) & CA 2965467 A & AU 2015336458 A & TW 201625533 A *; | [A] - YUSAKU SHIOJI, Manufacture Technology of Solid Tablet, Tokyo, (20030127), vol. 9, pages 12 - 13, XP009507058 [A] 1-21 | [A] - BYRN,S. et al., "Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950000), vol. 12, no. 7, pages 945 - 954, XP055399407 [A] 1-21 DOI: http://dx.doi.org/10.1023/A:1016241927429 | [A] - AKIRA OGATA, "Passage, KAGAKU JIKKEN SOSAHO", KAGAKU JIKKEN SOSAHO, (19631120), pages 366 - 399, XP009510132 [A] 1-21 | [A] - Chemical Society of Japan, "Passages, Jikken kagaku kōza zoku dai 2 (bunri to seisei) [Experimental Chemistry Course Sequel 2 (Separation and Purification)]", Jikken kagaku kōza zoku dai 2 (bunri to seisei) , (19670125), doi:10.11501/1369199, pages 159-162,184 - 193, XP009510623 [A] 1-21 DOI: http://dx.doi.org/10.11501/1369199 | [A] - "Jikken Kagaku Guidebook", The Chemical Society of Japan, JP, (19920430), ISBN 4-621-02830-8, pages 130 - 131, XP009510266 [A] 1-21 |